# PathAI

PathAI is an Asset Manager based in Boston, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Assets under management:** Undisclosed
- **Website:** pathai.com
- **LinkedIn:** https://www.linkedin.com/company/pathai

## Regulatory record

- **Reports private funds:** No

## About

At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clinicians.

## Sectors

- AI/ML
- Digital Health
- Healthcare Services

## Offices

- Princeton, NJ, United States
- Burlington, MA, United States

## Questions

### How does PathAI generate proprietary deal flow or revenue?

PathAI generates revenue through biopharma collaborations for biomarker discovery and drug development, deployment of its AISight platform to anatomic pathology laboratories, and its pathologist contributor network that provides annotation services for AI training (per the firm). The firm does not disclose revenue figures.

### Does PathAI participate in fund commitments or only direct deals?

PathAI operates as a venture-backed company, not as an asset manager making fund commitments. Its capital is deployed into product development, clinical trials, and commercial partnerships.

### What investment stages does PathAI typically target?

PathAI does not invest externally. It raises venture capital for its own operations; no public information on stage focus is available.

### Which sectors does PathAI explicitly focus on?

PathAI focuses exclusively on pathology and artificial intelligence for healthcare. Its products serve biopharma and clinical laboratories.

### How is PathAI related to any spinout or parent entity?

PathAI Diagnostics, the entity providing anatomic and digital pathology laboratory services, had select assets acquired by AmeriPath (a Quest Diagnostics company) on June 10, 2024 (per the firm). PathAI continues to operate its core technology and biopharma business.

### What is PathAI's known posture on co-investments alongside external GPs?

PathAI does not make co-investments alongside external GPs; it is an operating company not structured as an investment vehicle.

## Related profiles

- [The Narwhal Project](https://altss.com/profile/the-narwhal-project)
- [Komodo Health](https://altss.com/profile/komodo-health)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/pathai

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology